| 查看: 2495 | 回复: 6 | |||
| 本帖产生 1 个 LS-EPI ，点击这里进行查看 | |||
[求助]
求US 2007099998专利的Chem. Abstr.号
|
|||
| 怎么来搜索专利的CA号 |
回复此楼» 猜你喜欢
材料求调剂 一志愿哈工大总分298分，前三科223分
已经有5人回复
-
085600 286分 材料求调剂
已经有6人回复
-
086502化学工程342求调剂
已经有4人回复
-
材料求调剂一志愿哈工大324
已经有7人回复
-
328求调剂
已经有7人回复
-
340求调剂
已经有5人回复
-
一志愿南昌大学324求调剂
已经有4人回复
-
求调剂推荐 材料 304
已经有15人回复
-
291求调剂
已经有19人回复
-
331环境科学与工程求调剂
已经有3人回复
baiyuefei
版主 (文学泰斗)
风雪
- LS-EPI: 1647
- 应助: 4642 (副教授)
- 贵宾: 46.969
- 金币: 658108
- 散金: 11616
- 红花: 995
- 沙发: 81
- 帖子: 69424
- 在线: 13328.4小时
- 虫号: 676696
- 注册: 2008-12-18
- 性别: GG
- 专业: 合成药物化学
- 管辖: 有机交流
【答案】应助回帖
|
去CA检索即可 结果如下 Bibliographic Information Processes for preparing cinacalcet hydrochloride crystal form I. Lifshitz-Liron, Revital; Avhar-Maydan, Sharon. (Teva Pharmaceutical Industries Ltd., Israel; Teva Pharmaceuticals USA, Inc.). PCT Int. Appl. (2006), 25pp. CODEN: PIXXD2 WO 2006127933 A1 20061130 Designated States W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA. Designated States RW: AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IS, IT, LU, MC, NL, PT, SE, TR, BF, BJ, CF, CG, CI, CM, GA, ML, MR, NE, SN, TD, TG. Patent written in English. Application: WO 2006-US20304 20060523. Priority: US 2005-684152P 20050523; US 2005-696981P 20050705; US 2005-697111P 20050706; US 2005-698613P 20050711; US 2005-701232P 20050720; US 2005-702918P 20050726; US 2005-706910P 20050809; US 2005-730050P 20051024; US 2005-732083P 20051031; US 2005-733008P 20051102; US 2005-734669P 20051107; US 2005-735126P 20051108; US 2005-738827P 20051121; US 2005-741787P 20051201; US 2005-750910P 20051215; US 2006-794804P 20060424; WO 2006-US20304 20060523; EP 2006-771214 20060523; JP 2007-522852 20060523. CAN 146:13204 AN 2006:1251817 CAPLUS Patent Family Information Patent No. Kind Date Application No. Date WO 2006127933 A1 20061130 WO 2006-US20304 20060523 W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW RW: AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR, BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG, BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW, AM, AZ, BY, KG, KZ, MD, RU, TJ, TM CA 2606099 A1 20061130 CA 2006-2606099 20060523 US 20070060645 A1 20070315 US 2006-440246 20060523 US 7294735 B2 20071113 US 20070099998 A1 20070503 US 2006-439570 20060523 US 7247751 B2 20070724 BR 2006005859 A 20071218 BR 2006-5859 20060523 EP 1883618 A1 20080206 EP 2006-771215 20060523 EP 1883618 B1 20091014 R: AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR JP 2008507566 T 20080313 JP 2007-522852 20060523 JP 4638491 B2 20110223 EP 1975150 A1 20081001 EP 2008-12814 20060523 R: AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR AT 445587 T 20091015 AT 2006-771215 20060523 ES 2334260 T3 20100308 ES 2006-771215 20060523 MX 2007000983 A 20070416 MX 2007-983 20070123 KR 2007083471 A 20070824 KR 2007-7001966 20070126 IN 2007DN08108 A 20080704 IN 2007-DN8108 20071019 CN 101180261 A 20080514 CN 2006-80017939 20071123 JP 2010280715 A 20101216 JP 2010-197123 20100902 Priority Application US 2005-684152P P 20050523 US 2005-696981P P 20050705 US 2005-697111P P 20050706 US 2005-698613P P 20050711 US 2005-701232P P 20050720 US 2005-702918P P 20050726 US 2005-706910P P 20050809 US 2005-730050P P 20051024 US 2005-732083P P 20051031 US 2005-733008P P 20051102 US 2005-734669P P 20051107 US 2005-735126P P 20051108 US 2005-738827P P 20051121 US 2005-741787P P 20051201 US 2005-750910P P 20051215 US 2006-794804P P 20060424 WO 2006-US20304 W 20060523 EP 2006-771214 A3 20060523 JP 2007-522852 A3 20060523 Abstract The invention provides processes for the prepn. of cinacalcet-HCl cryst. Form I. Cinacalcet was dissolved in DMF and treated with 1N HCl to give the cryst. form I of the hydrochloride. Indexing -- Section 63-6 (Pharmaceuticals) Alcohols, uses Role: NUU (Other use, unclassified); USES (Uses) (C1-5; processes for prepg. cinacalcet hydrochloride crystal form I) Alcohols, uses Ethers, uses Role: NUU (Other use, unclassified); USES (Uses) (C2-5; processes for prepg. cinacalcet hydrochloride crystal form I) Aromatic hydrocarbons, uses Hydrocarbons, uses Ketones, uses Role: NUU (Other use, unclassified); USES (Uses) (C3-6; processes for prepg. cinacalcet hydrochloride crystal form I) Hydrocarbons, uses Role: NUU (Other use, unclassified); USES (Uses) (C5-8; processes for prepg. cinacalcet hydrochloride crystal form I) Crystal structure (of cinacalcet hydrochloride forms) Antisolvents Crystal morphology Crystal polymorphism (processes for prepg. cinacalcet hydrochloride crystal form I) Esters, uses Role: NUU (Other use, unclassified); USES (Uses) (processes for prepg. cinacalcet hydrochloride crystal form I) 60-29-7, Diethyl ether, uses 64-17-5, Ethyl alcohol, uses 67-56-1, Methanol, uses 67-63-0, IPA, uses 67-64-1, Acetone, uses 67-68-5, Dimethyl sulfoxide, uses 68-12-2, Dimethylformamide, uses 75-05-8, Acetonitrile, uses 108-88-3, Toluene, uses 109-66-0, Pentane, uses 110-19-0, Isobutyl acetate 110-54-3, Hexane, uses 110-82-7, Cyclohexane, uses 127-19-5, DMAc 142-82-5, Heptane, uses 872-50-4, N-Methylpyrrolidone, uses 1634-04-4, MTBE Role: NUU (Other use, unclassified); USES (Uses) (processes for prepg. cinacalcet hydrochloride crystal form I) 364782-34-3P, Cinacalcet hydrochloride Role: PRP (Properties); SPN (Synthetic preparation); THU (Therapeutic use); BIOL (Biological study); PREP (Preparation); USES (Uses) (processes for prepg. cinacalcet hydrochloride crystal form I) 226256-56-0, Cinacalcet Role: RCT (Reactant); THU (Therapeutic use); BIOL (Biological study); USES (Uses); RACT (Reactant or reagent) (processes for prepg. cinacalcet hydrochloride crystal form I) Supplementary Terms cinacalcet hydrochloride crystal form prepn Citations Iqbal, J; IDRUGS 2003, 6(6), 587 Anon; SUMMARY BASIS OF APPROVAL OF NEW DRUG APPLICATION #21-688 2004 |
2楼2012-04-16 15:19:30
baiyuefei
版主 (文学泰斗)
风雪
- LS-EPI: 1647
- 应助: 4642 (副教授)
- 贵宾: 46.969
- 金币: 658108
- 散金: 11616
- 红花: 995
- 沙发: 81
- 帖子: 69424
- 在线: 13328.4小时
- 虫号: 676696
- 注册: 2008-12-18
- 性别: GG
- 专业: 合成药物化学
- 管辖: 有机交流
3楼2012-04-16 15:19:57
4楼2012-04-16 15:46:06
5楼2012-04-16 15:53:37
baiyuefei
版主 (文学泰斗)
风雪
- LS-EPI: 1647
- 应助: 4642 (副教授)
- 贵宾: 46.969
- 金币: 658108
- 散金: 11616
- 红花: 995
- 沙发: 81
- 帖子: 69424
- 在线: 13328.4小时
- 虫号: 676696
- 注册: 2008-12-18
- 性别: GG
- 专业: 合成药物化学
- 管辖: 有机交流
6楼2012-04-16 16:03:33
xunmeng0011
铁杆木虫 (正式写手)
- 应助: 4 (幼儿园)
- 金币: 8982.1
- 散金: 1113
- 红花: 5
- 帖子: 717
- 在线: 189.6小时
- 虫号: 113244
- 注册: 2005-11-22
- 性别: GG
- 专业: 有机合成
7楼2017-10-17 14:15:13
